Minimally invasive surgery for gastro-oesophageal junction adenocarcinoma: Current evidence and future perspectives  

作　　者：Rodica Birla Petre Hoara Florin Achim Valeriu Dinca Diana Ciuc Silviu Constantinoiu Adrian Constantin 

机构地区：[1]Department of General Surgery,Carol Davila University,Bucharest 011172,Romania [2]Department of General Surgery,Carol Davila University of Medicine and Pharmacy,Bucharest 020021,Romania [3]Faculty of Medicine,“Titu Maiorescu”University,Bucharest 031593,Romania

出　　处：《World Journal of Gastrointestinal Oncology》2023年第10期1675-1690,共16页世界胃肠肿瘤学杂志（英文版）（电子版）

摘　　要：Minimally invasive surgery is increasingly indicated in the management of malignant disease.Although oesophagectomy is a difficult operation,with a long learning curve,there is actually a shift towards the laparoscopic/thoracoscopic/robotic approach,due to the advantages of visualization,surgeon comfort(robotic surgery)and the possibility of the whole team to see the operation as well as and the operating surgeon.Although currently there are still many controversial topics,about the surgical treatment of patients with gastro-oesophageal junction(GOJ)adenocarcinoma,such as the type of open or minimally invasive surgical approach,the type of oesophago-gastric resection,the type of lymph node dissection and others,the minimally invasive approach has proven to be a way to reduce postoperative complications of resection,especially by decreasing pulmonary complications.The implementation of new technologies allowed the widening of the range of indications for this type of surgical approach.The short-term and long-term results,as well as the benefits for the patient-reduced surgical trauma,quick and easy recovery-offer this type of surgical treatment the premises for future development.This article reviews the updates and perspectives on the minimally invasive approach for GOJ adenocarcinoma.

关 键 词：Gastro-oesophageal adenocarcinoma Minimally invasive oesophagectomy Laparoscopic gastrectomy Abdomino-mediastinal lymph node dissection Indocyanine green fluorescence imaging 

分 类 号：R735.2[医药卫生—肿瘤] R735.1[医药卫生—临床医学]